RESÚMENES NOVIEMBRE 2009

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

3 - Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

Ingrid Bacher , Becky Wu , Douglas R Shytle & Tony P George

Expert Opinion on Pharmacotherapy. November 2009, Vol. 10, No. 16, Pages 2709-2721

 

5< - Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study

Barbara Drueke, Julia Baetz, Maren Boecker, Olaf Moeller, Christoph Hiemke, Gerd Gründer and Siegfried Gauggel

Psychopharmacology. Volume 207, Number 2 / December, 2009: 213-223

 

3 - Anxiety and Outcome in Bipolar Disorder

William Coryell, David A. Solomon, Jess G. Fiedorowicz, Jean Endicott, Pamela J. Schettler, and Lewis L. Judd

Am J Psychiatry 2009; 166:1238-1243

 

3! - Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression. The REVAMP Trial

James H. Kocsis, Alan J. Gelenberg, Barbara O. Rothbaum, Daniel N. Klein, Madhukar H. Trivedi, Rachel Manber, Martin B. Keller, Andrew C. Leon, Steven R. Wisniewski, Bruce A. Arnow, John C. Markowitz, Michael E. Thase, for the REVAMP Investigators

Arch Gen Psychiatry. 2009;66(11):1178-1188

 

3 - Pharmacokinetic/Pharmacodynamic Modeling of Psychomotor Impairment Induced by Oral Clonazepam in Healthy Volunteers

Santos, Fábio Monteiro dos; Gonçalves, José Carlos Saraiva; Caminha, Ricardo; da Silveira, Gabriel Estolano; Neves, Claúdia Silvana de Miranda; Gram, Karla Regina da Silva; Ferreira, Carla Teixeira; Jacqmin, Philippe; Noël, François

Therapeutic Drug Monitoring: October 2009 - Volume 31 - Issue 5 - pp 566-574

 

3 - Formulations of Valproate Alter Valproate Metabolism: A Single Oral Dose Kinetic Study

Nagai, Goyo; Ono, Shingo; Yasui-Furukori, Norio; Nakamura, Akifumi; Mihara, Kazuo; Kondo, Tsuyoshi

Therapeutic Drug Monitoring: October 2009 - Volume 31 - Issue 5 - pp 592-596

 

3! - Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults

Robert H Howland

Neuropsychiatric Disease and Treatment. Published Date November 2009

 

3! - Effects of Glucocorticoids on Mood, Memory, and the Hippocampus. Treatment and Preventive Therapy

E. Sherwood Brown

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 41 - 55

 

3! - Sex Hormones and Mood in the Perimenopause

Peter J. Schmidt and David R. Rubinow

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 70 - 85

 

3! - Cytokines and Glucocorticoid Receptor Signaling. Relevance to Major Depression

Thaddeus W. W. Pace and Andrew H. Miller

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 86 - 105

 

3 - CRH Signaling. Molecular Specificity for Drug Targeting in the CNS

Damian Refojo and Florian Holsboer

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 106 - 119

 

3! - Risk Factors for Development of Depression and Psychosis. Glucocorticoid Receptors and Pituitary Implications for Treatment with Antidepressant and Glucocorticoids

Carmine M. Pariante

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 144 - 152

 

3! - Galantamine-ER For Cognitive Dysfunction In Bipolar Disorder and Correlation with Hippocampal Neuronal Viability: A Proof-of-Concept Study

Dan V. Iosifescu, Constance M. Moore, Thilo Deckersbach , Claire A. Tilley, Michael J. Ostacher, Gary S. Sachs, & Andrew A. Nierenberg

CNS Neuroscience & Therapeutics. Volume 15 Issue 4, Pages 309 - 319

 

3 - Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by Lithium

Antoni Camins, Ester Verdaguer, Felix Junyent, Marc Yeste-Velasco, Carme Pelegrí, Jordi Vilaplana & Mercé Pallás

CNS Neuroscience & Therapeutics. Volume 15 Issue 4, Pages 333 - 344

 

3 - Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice

Anil Kumar, Ruchika Garg, Vaibhav Gaur and Puneet Kumar

Neuroscience Letters. Volume 467, Issue 2, 25 December 2009, Pages 72-75

 

3 - Desipramine induced changes in the norepinephrine transporter, α- and γ-synuclein in the hippocampus, amygdala and striatum

Alexis M. Jeannotte, John G. McCarthy and Anita Sidhu

Neuroscience Letters. Volume 467, Issue 2, 25 December 2009, Pages 86-89

 

3! - Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model

D. Nutt, F. Mandel, F. Baldinetti

Journal of Psychopharmacology, Vol. 23, No. 8, 867-873 (2009)

 

3 - Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors — a new analysis of data from the archives and implications for improved antimanic treatments

PE Harrison-Read

Journal of Psychopharmacology, Vol. 23, No. 8, 899-907 (2009)

 

3 - Sex-related differential response to clomipramine treatment in a rat model of depression

N. Kokras, K. Antoniou, C. Dalla, S. Bekris, M. Xagoraris, DH Ovestreet, Z. Papadopoulou-Daifoti

Journal of Psychopharmacology, Vol. 23, No. 8, 945-956 (2009)

 

3 - Is phosphoadenosine phosphate phosphatase a target of lithium’s therapeutic effect?

G. Shaltiel, J. Deutsch, S. I. Rapoport, M. Basselin, R. H. Belmaker and G. Agam

Journal of Neural Transmission. Volume 116, Number 11 / November, 2009: 1543-1549

 

4 - Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being Outcome Measures in Patients With Major Depressive Disorder: A Pooled Analysis of 9 Double-Blind, Placebo-Controlled, 8-Week Clinical Trials

Claudio N. Soares, Susan G. Kornstein, Michael E. Thase, Qin Jiang, and Christine J. Guico-Pabia

J Clin Psychiatry 2009;70(10):1365–1371

 

4 - Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post Hoc Analysis

Franco Benazzi, Michael Berk, Mark A. Frye, Wei Wang, Alessandra Barraco, and Mauricio Tohen

J Clin Psychiatry 2009;70(10):1424–1431

 

3 - Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression

Arif Khan

Expert Opinion on Investigational Drugs. November 2009, Vol. 18, No. 11, Pages 1753-1764

 

3! - Meta-analysis of initial seizure thresholds in electroconvulsive therapy

Jeroen A. van Waarde, Bastiaan Verwey and Rose C. van der Mast

European Archives of Psychiatry and Clinical Neuroscience. Volume 259, Number 8 / December, 2009: 467-474

 

3 - Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: Comparison between milnacipran and paroxetine

Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, Wakako Umene-Nakano, Nobuhisa Ueda and Jun Nakamura

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 8, 13 November 2009, Pages 1451-1453

3! - Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial

A. H. Behzadi, Z. Omrani, M. Chalian, S. Asadi, M. Ghadiri

Acta Psychiatrica Scandinavica. Volume 120 Issue 6, Pages 441 - 445

 

3! - Is bipolar II depression phenotypically distinctive?

G. B. Parker, K. Fletcher

Acta Psychiatrica Scandinavica. Volume 120 Issue 6, Pages 446 - 455

 

3 - The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ

U. Goswami, A. Sharma, A. Varma, C. Gulrajani, I. N. Ferrier, A. H. Young, P. Gallagher, J. M. Thompson, P. B. Moore

Acta Psychiatrica Scandinavica. Volume 120 Issue 6, Pages 456 - 463

 

3 - Gender differences in bipolar disorder type I and II

K. Suominen, O. Mantere, H. Valtonen, P. Arvilommi, S. Leppämäki, E. Isometsä

Acta Psychiatrica Scandinavica. Volume 120 Issue 6, Pages 464 - 473

 

4 - Number Needed to Treat or Harm Analyses of Olanzapine for Maintenance Treatment of Bipolar Disorder

Tohen, Mauricio; Sniadecki, Jennifer; Sutton, Virginia K; Degenhardt, Elisabeth K; Karagianis, Jamie L; Sagman, Doron; Jacobson, Jennie G

Journal of Clinical Psychopharmacology: December 2009 - Volume 29 - Issue 6 - pp 520-528

 

3! - Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth Restriction

Toh, Sengwee; Mitchell, Allen A; Louik, Carol; Werler, Martha M; Chambers, Christina D; Hernández-Díaz, Sonia

Journal of Clinical Psychopharmacology: December 2009 - Volume 29 - Issue 6 - pp 555-560

 

5< - A Randomized Controlled Trial of Atomoxetine in Generalized Social Anxiety Disorder

Ravindran, Lakshmi N; Kim, Daniel S; Letamendi, Andrea M; Stein, Murray B

Journal of Clinical Psychopharmacology: December 2009 - Volume 29 - Issue 6 - pp 561-564

 

3 - Depressive Symptomatology, Rather than Neuroticism, Predicts Inflated Physical Symptom Reports in Community-Residing Women

M. Bryant Howren, Jerry Suls, and René Martin

Psychosomatic Medicine 71:951-957 (2009)

GRATIS 3 - Do Depressed Patients With Diabetes Experience More Side Effects When Treated With Citalopram Than Their Counterparts Without Diabetes? A STAR*D Study

Charlene Bryan, Thomas Songer, Maria Mori Brooks, Michael E. Thase, Bradley Gaynes, Michael Klinkman, G. K. Balasubramani, A. John Rush, Madhukar H. Trivedi, Maurizio Fava, and Stephen R. Wisniewski

Prim Care Companion J Clin Psychiatry 2009;11(5):186-196

 

GRATIS 4 - Quetiapine Monotherapy as Treatment for Anxiety Symptoms in Patients With Bipolar Depression: A Pooled Analysis of Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies

R. Bruce Lydiard, Larry Culpepper, Helena Schiöler, Urban Gustafsson, and Björn Paulsson

Prim Care Companion J Clin Psychiatry 2009;11(5):215­225

 

GRATIS 3 - Augmentation Effect of Repetitive Transcranial Magnetic Stimulation Over the Orbitofrontal Cortex in Drug-Resistant Obsessive-Compulsive Disorder Patients: A Controlled Investigation

Chiara Ruffini, Marco Locatelli, Adelio Lucca, Francesco Benedetti, Chiara Insacco, and Enrico Smeraldi

Prim Care Companion J Clin Psychiatry 2009;11(5):226­230

 

3 - Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk?

C. Barr Taylor, Ansgar Conrad, Frank H. Wilhelm, Diane Strachowski, Anna Khaylis, Eric Neri, Janine Giese-Davis, Walton T Roth, John P. Cooke, Helena Kraemer and David Spiegel

Journal of Psychiatric Research. Volume 43, Issue 16, December 2009, Pages 1246-1252

 

5 - Asenapine versus olanzapine in acute mania: a double-blind extension study

Roger S McIntyre, Miriam Cohen, Jun Zhao, Larry Alphs, Thomas A Macek and John Panagides

Bipolar Disorders. Volume 11 Issue 8, Pages 815 - 826

 

5 - A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently

Wayne Macfadden, Larry Alphs, J Thomas Haskins, Norris Turner, Ibrahim Turkoz, Cynthia Bossie, Mary Kujawa and Ramy Mahmoud

Bipolar Disorders. Volume 11 Issue 8, Pages 827 - 839

 

3 - Stability of symptoms across major depressive episodes in bipolar disorder

Roy H Perlis, Michael J Ostacher, Rudolf Uher, Andrew A Nierenberg, Francesco Casamassima, Christine Kansky, Joseph R Calabrese, Michael Thase, Gary S Sachs

Bipolar Disorders. Volume 11 Issue 8, Pages 867 - 875

 

3! - Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect

Liad Mann, Eliahu Heldman, Yuly Bersudsky, Stephen F Vatner, Yoshihiro Ishikawa, Orna Almog, Robert H Belmaker, Galila Agam

Bipolar Disorders. Volume 11 Issue 8, Pages 885 - 896

 

GRATIS 3! - Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability

Andre R Brunoni, Renerio Fraguas Jr, Felipe Fregni

Therapeutics and Clinical Risk Management. Published Date November 2009

 

3 - Depressive Symptoms and Metabolic Syndrome: Selective Association in Older Women

Alice Laudisio, Emanuele Marzetti, Francesco Pagano, Gino Pozzi, Roberto Bernabei, Giuseppe Zuccalà

Journal of Geriatric Psychiatry and Neurology, Vol. 22, No. 4, 215-222 (2009)

 

5 - The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder: A Systematic Review and Meta-Analysis

Gartlehner, Gerald; Thaler, Kylie; Hansen, Richard A; Gaynes, Bradley N

Drug Safety: 1 December 2009 - Volume 32 - Issue 12 - pp 1159-1173

 

5< - Effects of the GABA-reuptake Inhibitor Tiagabine on Panic and Anxiety in Patients with Panic Disorder

P. Zwanzger, D. Eser, C. Nothdurfter, T. C. Baghai, H.-J. Möller, F. Padberg, R. Rupprecht

Pharmacopsychiatry 2009; 42: 266-269

GRATIS 3 - Pharmacotherapy of Major Depressive Disorder: Focus  on Duloxetine

Katsumasa Muneoka

Clinical Medicine: Therapeutics 2009:1 1541-1556

 

3 - Preliminary Findings Concerning the Use of Prazosin for the Treatment of Posttraumatic Nightmares in a Refugee Population

Boynton, Lorin; Bentley, Jacob; Strachan, Eric; Barbato, Anna; Raskind, Murray

Journal of Psychiatric Practice: November 2009 - Volume 15 - Issue 6 - pp 454-459

 

2! - Medically Unexplained Physical Symptoms in Elderly People: A Pilot Study of Psychiatric Geriatric Characteristics

Hilderink, Peter H; Benraad, Caroline E; van Driel, Dorine; Buitelaar, Jan K; Speckens, Anne E; Olde Rikkert, Marcel G; Voshaar, Richard C. Oude

American Journal of Geriatric Psychiatry: December 2009 - Volume 17 - Issue 12 - pp 1085-1088

 

GRATIS 3 - Modifiable risk factors predicting major depressive disorder at four year follow-up: a decision tree approach

Philip J Batterham, Helen Christensen and Andrew J Mackinnon

BMC Psychiatry 2009, 9:75

 

3 - Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression

Xiaobin Zhang, Zhijun Zhang, Weiwei Sha, Chunming Xie, Guangjun Xi, Honghui Zhou and Yumei Zhang

Psychiatry Research. Volume 170, Issues 2-3, 30 December 2009, Pages 273-275

 

3 - Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons

Noam S Katz, Bruno P Guiard, Mostafa El Mansari, and Pierre Blier

Journal of Psychopharmacology. First published on November 25, 2009

5 - Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

Karen Hewett, Michelle D. Gee, Alok Krishen, Hans-Peter Wunderlich, Alfred Le Clus, Gary Evoniuk, and Jack G. Modell

Journal of Psychopharmacology. First published on November 25, 2009

3 - Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression

Doron Todder , Serdal Caliskan , Bernhard T. Baune

World Journal of Biological Psychiatry. 2009, Vol. 10, No. 4, Pages 276-284

 

3 - Cortical neurochemistry in euthymic patients with bipolar I disorder

Harald Scherk , Martin Backens , Thomas Schneider-Axmann , Juliana Usher , Claudia Kemmer , Wolfgang Reith , Peter Falkai , Oliver Gruber

World Journal of Biological Psychiatry. 2009, Vol. 10, No. 4, Pages 285-294

 

3 - Pro-inflammatory biomakers in depression: Treatment with venlafaxine

John E. Piletz, Angelos Halaris , Omer Iqbal , Debra Hoppensteadt , Jawed Fareed , He Zhu , James Sinacore , C. Lindsay DeVane

World Journal of Biological Psychiatry. 2009, Vol. 10, No. 4, Pages 313-323

 

3 - Depressive disorder and thyroid axis functioning during pregnancy

Robertas Bunevicius,  Laima Kusminskas , Narseta Mickuviene , Adomas Bunevicius, Cort A. Pedersen , Victor J.M. Pop

World Journal of Biological Psychiatry. 2009, Vol. 10, No. 4, Pages 324-329

 

3 - Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood–brain barrier: an experimental PET study in rats

Onno L. de Klerk, Fokko J Bosker, Antoon T. M. Willemsen, Aren van Waarde, Anniek K. D. Visser, Tim de Jager, Girstaute Dagyte, Johan A. den Boer, Rudi A Dierckx, and Peter Meerlo

Journal of Psychopharmacology. First published on November 26, 2009

3 - Diencephalic Serotonin Transporter Availability Predicts Both Transporter Occupancy and Treatment Response to Sertraline in Obsessive-Compulsive Checkers

Werner Zitterl, Thomas Stompe, Martin Aigner, Karin Zitterl-Eglseer, Kristina Ritter, Georg Zettinig, Kurt Hornik, Susanne Asenbaum, Walter Pirker and Kenneth Thau

Biological Psychiatry. Volume 66, Issue 12, 15 December 2009, Pages 1115-1122

3 - Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder

Ditte Dencker and Henriette Husum

Behavioural Brain Research. Volume 207, Issue 1, 11 February 2010, Pages 78-83

 

3 - Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine

Jing Liu, Jacob C. Garza, Jamaur Bronner, Chung Sub Kim, Wei Zhang and Xin-Yun Lu

Psychopharmacology. Volume 207, Number 4 / January, 2010: 535-545

 

5< - Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy clinicians

Nathalie Besnier, Catherine Cassé-Perrot, Elisabeth Jouve, Nhan Nguyen, Christophe Lançon, Bruno Falissard and Olivier Blin

Psychopharmacology. Volume 207, Number 4 / January, 2010: 619-629

 

3 - Pre-, Peri- and Postpartal Depression. First Cognition from FRAMES (Franconian Maternal Health Evaluation Studies)

U. Reulbach, S. Bleich, J. Knörr, P. Burger, P. A. Fasching, J. Kornhuber, M. W. Beckmann, T. W. Goecke

Fortschr Neurol Psychiatr 2009; 77: 708-713

GRATIS (previo registro) 3 - Uso de los tratamientos antidepresivos. La percepción del paciente

M. J. Martín,  M. García-Toro,  F. Campoamor,  A. Pareja,  I. Aguirre,  J. Salvá y M. Roca

Actas Esp Psiquiatr 2009;37(5):276-281

 

GRATIS (previo registro) 3 - Pronóstico de la depresión en la tercera edad en comparación con la edad adulta. ¿Existe una diferencia clínica significativa?

A. J. Mitchell y A. Izquierdo de Santiago

Actas Esp Psiquiatr 2009;37(5):289-296

 

GRATIS 3! - Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder?

Martin Alda, Lakshmi N Yatham

Can J Psychiatry. 2009;54(11):719–725

 

GRATIS 3! - Mechanism of Action of Trazodone: a Multifunctional Drug

Stephen M. Stahl

CNS Spectr. 2009;14(8):412-414

 

GRATIS (previo registro) 3 - Depression has a Strong Relationship to Alterations in the Immune, Endocrine and Neural System

Knut A. Hestad, Pal Aukrust, Sverre Tonseth, Solveig Klæbo Reita

Current Psychiatry Reviews. 2009; Volume 5 Issue 4: 287-297

GRATIS (previo registro) 3 - The Role of Dopaminergic Agents in Improving Quality of Life in Major Depressive Disorder

Waguih William IsHak, Michael Davis, Jessica Jeffrey, Konstantin Balayan, Robert N. Pechnick, Kara Bagot, and Mark Hyman Rapaport  
Current Psychiatry Reports 2009, 11: (6) 503-508

 

GRATIS (previo registro) 3! - Melatonin, Circadian Rhythms, and the Clock Genes in Bipolar Disorder

Sara Dallaspezia, and Francesco Benedetti  
Current Psychiatry Reports 2009, 11: (6) 488-493

 

GRATIS (previo registro) 3! - Impulsivity in Mania

Alan C. Swann  
Current Psychiatry Reports 2009, 11: (6) 481-487

 

GRATIS (previo registro) 3 -  Mania and Mortality: Why the Excess Cardiovascular Risk in Bipolar Disorder?

Dylan P. Murray, Miriam Weiner, Maithri Prabhakar, and Jess G. Fiedorowicz  
Current Psychiatry Reports 2009, 11: (6) 475-480

 

GRATIS (previo registro) 3 -  Exercise in the Treatment of Depression

Tracy L. Greer, and Madhukar H. Trivedi
Current Psychiatry Reports 2009, 11: (6) 466-472

 

GRATIS (previo registro) 3! - Circadian Misalignment in Mood Disturbances

Alfred J. Lewy  
Current Psychiatry Reports 2009, 11: (6) 459-465

 

GRATIS (previo registro) 3 - Transcranial Magnetic Stimulation in the Treatment of Psychiatric Disorders

Deborah R. Kim, Angeliki Pesiridou, and John P. O’Reardon
Current Psychiatry Reports 2009, 11: (6) 447-452

 

GRATIS (previo registro) 3 - Pregnancy and Depression: Exploring a New Potential Treatment Option

Deborah R. Kim, Juan Gonzalez, and John P. O’Reardon  
Current Psychiatry Reports 2009, 11: (6) 443-446

 

GRATIS (previo registro) 3 - Insomnia and Depression: A Multifaceted Interplay

Rachel Manber, and Andrea S. Chambers  
Current Psychiatry Reports 2009, 11: (6) 437-442

 

GRATIS (previo registro) 3 - Anxious Depression: Clinical Features and Treatment

Sanjai Rao, and Sidney Zisook
Current Psychiatry Reports 2009, 11: (6) 429-436

 

GRATIS 3 - Depression During Pregnancy

Katherine L. Wisner

Psychiatric Times. Vol. 26 No. 11; November 4, 2009 

.

Regresar a RESÚMENES NOVIEMBRE 2009

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.